Global Congress on Prostate Cancer - PROSCA 2020

 

Global Congress on Prostate Cancer - PROSCA 2020
E

2020 Update on mCRPC: Which Patients Can Benefit From PARPi? Can Previous Therapies Affect the Response to PARPi?

By Global Congress on Prostate Cancer - PROSCA 2020 FEATURING Elena Castro
By Global Congress on Prostate Cancer - PROSCA 2020 FEATURING Elena Castro
117 views
November 26, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Videos
17:52
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on MRI in PC: What Are the Guidelines for Delivering a H…

Feat. A. Padhani
16:06
Global Congress on Prostate Cancer - PROSCA 2020

2020 Updates on mHSPC: DT + RT, ADT + 6 Cycles Docetaxel, or Novel A…

Feat. U. Vogl
13:52
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on mCRPC: Which Patients Can Benefit From PARPi? Can Pre…

Feat. E. Castro
19:37
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on PSMA-PET in PC: Does It Make a Difference for Patient…

Feat. J. Calais
21:38
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on IO for Advanced PC: Is There an OS Benefit w/ Sipuleu…

Feat. P. Grivas
18:34
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on nmCRPC: Are Apalutamide, Darolutamide & Enzalutam…

Feat. C. Ryan
17:06
Global Congress on Prostate Cancer - PROSCA 2020

2020 Update on MRI in Active Surveillance for PC: What Is the Aim, E…

Feat. J. Stranne
13:51
Global Congress on Prostate Cancer - PROSCA 2020

PC Robotic Radical Prostatectomy at Mount Sinai Health: How Does Hoo…

Feat. A. Tewari